Utility, benefits, and risks of newborn genetic screening carrier reports for families
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background: Newborn genetic screening (NBGS) based on next-generation sequencing offers enhanced disease detection and better detection rates than traditional newborn screening. However, challenges remain, especially around reporting the NBGS carrier results. Therefore, we aimed to investigate the NBGS carrier parents' views on NBGS and NBGS reports in China. Methods: We distributed a survey querying demographic information, knowledge and perceptions of NBGS, the impact of NBGS on a total of 2930 parents, and their decision-making to parents of newborns reported as carriers in NBGS in Nanjing, China in 2022. Results: The average age of the survey respondents was 30.7 years (standard deviation = 3.6). Most (68.38%) felt informed about NBGS, especially women, the highly educated, and high earners. Nearly all (98.74%) saw NBGS as crucial for early disease detection, with 73.18% believing it positively impacts their future. However, 19.16% felt it might cause anxiety, especially among the less educated. Concerns included potential discrimination due to exposed genetic data and strained family ties. Many suggested NBGS coverage by medical insurance to ease financial burdens. Conclusions: Through our study, we gained insights into parents' perspectives and concerns regarding the NBGS carrier result reporting, thus providing relevant information for further refinement and clinical promotion of the NBGS project.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Utility, benefits, and risks of newborn genetic screening carrier reports for families
- Date Crossref
- 23/02/2024
- Éditeur
- International Society of Global Health
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Nanjing Maternity and Child Health Care Hospital pays non établi dans la noticeÉtablissement de santé
-
Nanjing Medical University Genetic Medicine Center pays non établi dans la noticeUniversité ou école supérieure
-
BGI Group (China) pays non établi dans la noticeEntreprise
-
BGI Genomics pays non établi dans la noticeEntreprise
-
Clin Lab pays non établi dans la noticeStructure de recherche
Nanjing Maternity and Child Health Care Hospital, Genetic Medicine Center — Nanjing Medical University et BGI Group (China), avec 2 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.